References
- Barnard N.J., Hall P.A., Lemoine N.R., Kadar N. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. Journal of Pathology 1987; 152: 223–235
- Begg A.C., McNally N.J., Shrieve D.C., Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–626
- Bush C., Price P., Parkins C., Bailey M., Jones C., Horwich A. Proliferative fraction in human bladder carcinoma measured by Ki67 antibody labelling — its potential clinical use. International Journal of Radiation Biology 1989; 56
- Gatter K.C., Dunnill M.S., Gerdes J., Stein H., Mason D.Y. New approach to assessing lung tumours in man. Journal of Clinical Pathology 1986; 39: 590–593
- Gerdes J., Schwab U., Lenke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. International Journal of Cancer 1983; 31: 13–20
- Gerdes J., Lemke H., Baisch H., Walker H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. Journal of Immunology 1984; 133: 1710–1715
- Hall P.A., Richards M.A., Gregory W.M., d'Ardenne A.J., Lister J.A., Stansfield A.G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. Journal of Pathology 1988; 154: 223–235
- Loke S.L., Jaffe E.S., Neckers L.M. Inhibition of in vitro DNA synthesis by the monoclonal antibody Ki67. Blood 1987; 70(1), 157a No. 484